Medtronic executives to speak at the Evercore ISI 5th annual HealthCONx conference

Rhea-AI Summary

Medtronic plc (NYSE:MDT) will participate in the Evercore ISI 5th annual HealthCONx conference on November 29, 2022. Geoff Martha, CEO, and Karen Parkhill, CFO, will address questions starting at 5:10 p.m. EST. A live webcast will be accessible via the Investor Events link at Medtronic's Investor Relations, with an archived session available later. Medtronic is a leader in healthcare technology, committed to addressing complex health issues globally.

DUBLIN, Nov. 23, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the Evercore ISI 5^th annual HealthCONx conference on Tuesday, November 29, 2022. 

Geoff Martha, Medtronic chairman and chief executive officer, and Karen Parkhill, executive vice president & chief financial officer, will answer questions on the company beginning at 5:10 p.m. EST (4:10 p.m. CST).

 A live webcast of the Q&A session will be available on November 29, 2022, by clicking on the Investor Events link at http://investorrelations.medtronic.com. An archive of the Q&A session will be available on the same webpage later in the day.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Erika Winkels	Ryan Weispfenning
Public Relations	Investor Relations
+1-763-526-8478	+1-763-505-4626

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-executives-to-speak-at-the-evercore-isi-5th-annual-healthconx-conference-301686196.html

SOURCE Medtronic plc

FAQ

When is Medtronic's participation in the Evercore ISI HealthCONx conference?

Medtronic will participate in the Evercore ISI 5th annual HealthCONx conference on November 29, 2022.

Who will be speaking at the Evercore ISI HealthCONx conference for Medtronic?

Geoff Martha, CEO, and Karen Parkhill, CFO, will represent Medtronic during the conference.

What time will Medtronic's Q&A session start at the conference?

The Q&A session will begin at 5:10 p.m. EST.

How can I watch the Medtronic Q&A session from the conference?

The session will be available via live webcast on Medtronic's Investor Relations website.

Where can I find the archived session of the Medtronic conference Q&A?

An archive of the Q&A session will be available on Medtronic's Investor Relations page later on November 29, 2022.